| UniProt ID | BUD13_HUMAN | |
|---|---|---|
| UniProt AC | Q9BRD0 | |
| Protein Name | BUD13 homolog | |
| Gene Name | BUD13 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 619 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MAAAPPLSKAEYLKRYLSGADAGVDRGSESGRKRRKKRPKPGGAGGKGMRIVDDDVSWTAISTTKLEKEEEEDDGDLPVVAEFVDERPEEVKQMEAFRSSAKWKLLGGHNEDLPSNRHFRHDTPDSSPRRVRHGTPDPSPRKDRHDTPDPSPRRARHDTPDPSPLRGARHDSDTSPPRRIRHDSSDTSPPRRARHDSPDPSPPRRPQHNSSGASPRRVRHDSPDPSPPRRARHGSSDISSPRRVHNNSPDTSRRTLGSSDTQQLRRARHDSPDLAPNVTYSLPRTKSGKAPERASSKTSPHWKESGASHLSFPKNSKYEYDPDISPPRKKQAKSHFGDKKQLDSKGDCQKATDSDLSSPRHKQSPGHQDSDSDLSPPRNRPRHRSSDSDLSPPRRRQRTKSSDSDLSPPRRSQPPGKKAAHMYSGAKTGLVLTDIQREQQELKEQDQETMAFEAEFQYAETVFRDKSGRKRNLKLERLEQRRKAEKDSERDELYAQWGKGLAQSRQQQQNVEDAMKEMQKPLARYIDDEDLDRMLREQEREGDPMANFIKKNKAKENKNKKVRPRYSGPAPPPNRFNIWPGYRWDGVDRSNGFEQKRFARLASKKAVEELAYKWSVEDM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 16 | Phosphorylation | KAEYLKRYLSGADAG HHHHHHHHHHCCCCC | 12.02 | 29978859 | |
| 18 | Phosphorylation | EYLKRYLSGADAGVD HHHHHHHHCCCCCCC | 24.01 | 25159151 | |
| 26 | Methylation | GADAGVDRGSESGRK CCCCCCCCCCHHHCC | 48.40 | - | |
| 28 | Phosphorylation | DAGVDRGSESGRKRR CCCCCCCCHHHCCCC | 29.50 | 25159151 | |
| 30 | Phosphorylation | GVDRGSESGRKRRKK CCCCCCHHHCCCCCC | 45.66 | 30576142 | |
| 40 | Acetylation | KRRKKRPKPGGAGGK CCCCCCCCCCCCCCC | 61.40 | 18585327 | |
| 47 | Acetylation | KPGGAGGKGMRIVDD CCCCCCCCCCEECCC | 48.92 | 90929 | |
| 57 | Phosphorylation | RIVDDDVSWTAISTT EECCCCCCEEEEECC | 26.21 | 28348404 | |
| 59 | Phosphorylation | VDDDVSWTAISTTKL CCCCCCEEEEECCCC | 13.45 | 28348404 | |
| 65 | Sumoylation | WTAISTTKLEKEEEE EEEEECCCCCHHHHC | 55.53 | - | |
| 65 | Sumoylation | WTAISTTKLEKEEEE EEEEECCCCCHHHHC | 55.53 | 28112733 | |
| 92 | Ubiquitination | DERPEEVKQMEAFRS CCCHHHHHHHHHHHH | 47.40 | - | |
| 99 | Phosphorylation | KQMEAFRSSAKWKLL HHHHHHHHHHHHHHH | 28.35 | 28102081 | |
| 100 | Phosphorylation | QMEAFRSSAKWKLLG HHHHHHHHHHHHHHC | 29.61 | 23917254 | |
| 104 | Ubiquitination | FRSSAKWKLLGGHNE HHHHHHHHHHCCCCC | 32.88 | - | |
| 115 | Phosphorylation | GHNEDLPSNRHFRHD CCCCCCCCCCCCCCC | 54.52 | 21406692 | |
| 123 | Phosphorylation | NRHFRHDTPDSSPRR CCCCCCCCCCCCCCC | 23.91 | 23401153 | |
| 126 | Phosphorylation | FRHDTPDSSPRRVRH CCCCCCCCCCCCCCC | 43.37 | 23401153 | |
| 127 | Phosphorylation | RHDTPDSSPRRVRHG CCCCCCCCCCCCCCC | 29.79 | 29255136 | |
| 135 | Phosphorylation | PRRVRHGTPDPSPRK CCCCCCCCCCCCCCC | 20.56 | 29255136 | |
| 139 | Phosphorylation | RHGTPDPSPRKDRHD CCCCCCCCCCCCCCC | 44.72 | 29255136 | |
| 147 | Phosphorylation | PRKDRHDTPDPSPRR CCCCCCCCCCCCCCC | 24.38 | 29255136 | |
| 151 | Phosphorylation | RHDTPDPSPRRARHD CCCCCCCCCCCCCCC | 38.12 | 29255136 | |
| 159 | Phosphorylation | PRRARHDTPDPSPLR CCCCCCCCCCCCCCC | 24.38 | 29255136 | |
| 163 | Phosphorylation | RHDTPDPSPLRGARH CCCCCCCCCCCCCCC | 43.90 | 29255136 | |
| 172 | Phosphorylation | LRGARHDSDTSPPRR CCCCCCCCCCCCCCC | 36.34 | 29255136 | |
| 174 | Phosphorylation | GARHDSDTSPPRRIR CCCCCCCCCCCCCCC | 47.27 | 29255136 | |
| 175 | Phosphorylation | ARHDSDTSPPRRIRH CCCCCCCCCCCCCCC | 37.59 | 29255136 | |
| 184 | Phosphorylation | PRRIRHDSSDTSPPR CCCCCCCCCCCCCCC | 24.80 | 20164059 | |
| 185 | Phosphorylation | RRIRHDSSDTSPPRR CCCCCCCCCCCCCCH | 51.47 | 20164059 | |
| 187 | Phosphorylation | IRHDSSDTSPPRRAR CCCCCCCCCCCCHHC | 45.11 | 21955146 | |
| 188 | Phosphorylation | RHDSSDTSPPRRARH CCCCCCCCCCCHHCC | 37.59 | 26055452 | |
| 197 | Phosphorylation | PRRARHDSPDPSPPR CCHHCCCCCCCCCCC | 25.69 | 29255136 | |
| 201 | Phosphorylation | RHDSPDPSPPRRPQH CCCCCCCCCCCCCCC | 55.72 | 29255136 | |
| 201 (in isoform 2) | Phosphorylation | - | 55.72 | 29743597 | |
| 210 | Phosphorylation | PRRPQHNSSGASPRR CCCCCCCCCCCCCCC | 28.20 | 23927012 | |
| 211 | Phosphorylation | RRPQHNSSGASPRRV CCCCCCCCCCCCCCC | 43.63 | 23927012 | |
| 214 | Phosphorylation | QHNSSGASPRRVRHD CCCCCCCCCCCCCCC | 23.59 | 20201521 | |
| 220 (in isoform 2) | Phosphorylation | - | 36.72 | 29743597 | |
| 222 | Phosphorylation | PRRVRHDSPDPSPPR CCCCCCCCCCCCCCC | 25.69 | 29255136 | |
| 224 (in isoform 2) | Phosphorylation | - | 61.33 | 29743597 | |
| 226 | Phosphorylation | RHDSPDPSPPRRARH CCCCCCCCCCCCCCC | 55.72 | 29255136 | |
| 235 | Phosphorylation | PRRARHGSSDISSPR CCCCCCCCCCCCCCC | 20.79 | 29255136 | |
| 236 | Phosphorylation | RRARHGSSDISSPRR CCCCCCCCCCCCCCC | 43.48 | 29255136 | |
| 239 | Phosphorylation | RHGSSDISSPRRVHN CCCCCCCCCCCCCCC | 39.00 | 29255136 | |
| 240 | Phosphorylation | HGSSDISSPRRVHNN CCCCCCCCCCCCCCC | 23.82 | 29255136 | |
| 248 | Phosphorylation | PRRVHNNSPDTSRRT CCCCCCCCCCCCHHC | 29.48 | 29255136 | |
| 251 | Phosphorylation | VHNNSPDTSRRTLGS CCCCCCCCCHHCCCC | 27.76 | 29255136 | |
| 252 | Phosphorylation | HNNSPDTSRRTLGSS CCCCCCCCHHCCCCC | 27.43 | 29255136 | |
| 255 | Phosphorylation | SPDTSRRTLGSSDTQ CCCCCHHCCCCCHHH | 34.07 | 25159151 | |
| 258 | Phosphorylation | TSRRTLGSSDTQQLR CCHHCCCCCHHHHHH | 28.31 | 25159151 | |
| 259 | Phosphorylation | SRRTLGSSDTQQLRR CHHCCCCCHHHHHHH | 42.76 | 25159151 | |
| 261 | Phosphorylation | RTLGSSDTQQLRRAR HCCCCCHHHHHHHHH | 21.84 | 29396449 | |
| 271 | Phosphorylation | LRRARHDSPDLAPNV HHHHHCCCCCCCCCC | 17.75 | 29255136 | |
| 279 | Phosphorylation | PDLAPNVTYSLPRTK CCCCCCCEEECCCCC | 17.65 | 25159151 | |
| 280 | Phosphorylation | DLAPNVTYSLPRTKS CCCCCCEEECCCCCC | 12.15 | 21712546 | |
| 281 | Phosphorylation | LAPNVTYSLPRTKSG CCCCCEEECCCCCCC | 23.64 | 25159151 | |
| 295 | Phosphorylation | GKAPERASSKTSPHW CCCCCCCCCCCCCCH | 38.29 | 23403867 | |
| 296 | Phosphorylation | KAPERASSKTSPHWK CCCCCCCCCCCCCHH | 38.68 | 23403867 | |
| 298 | Phosphorylation | PERASSKTSPHWKES CCCCCCCCCCCHHHC | 49.81 | 26657352 | |
| 299 | Phosphorylation | ERASSKTSPHWKESG CCCCCCCCCCHHHCC | 20.64 | 25159151 | |
| 305 | Phosphorylation | TSPHWKESGASHLSF CCCCHHHCCCCCCCC | 35.61 | 21949786 | |
| 308 | Phosphorylation | HWKESGASHLSFPKN CHHHCCCCCCCCCCC | 28.61 | 25159151 | |
| 311 | Phosphorylation | ESGASHLSFPKNSKY HCCCCCCCCCCCCCC | 33.79 | 25159151 | |
| 318 | Phosphorylation | SFPKNSKYEYDPDIS CCCCCCCCCCCCCCC | 21.39 | 23927012 | |
| 320 | Phosphorylation | PKNSKYEYDPDISPP CCCCCCCCCCCCCCC | 29.68 | 23927012 | |
| 325 | Phosphorylation | YEYDPDISPPRKKQA CCCCCCCCCCCHHHH | 35.91 | 19664994 | |
| 352 | Phosphorylation | KGDCQKATDSDLSSP CCCHHHCCCCCCCCC | 42.97 | 24732914 | |
| 354 | Phosphorylation | DCQKATDSDLSSPRH CHHHCCCCCCCCCCH | 35.78 | 30266825 | |
| 357 | Phosphorylation | KATDSDLSSPRHKQS HCCCCCCCCCCHHCC | 43.20 | 30266825 | |
| 358 | Phosphorylation | ATDSDLSSPRHKQSP CCCCCCCCCCHHCCC | 33.00 | 29255136 | |
| 364 | Phosphorylation | SSPRHKQSPGHQDSD CCCCHHCCCCCCCCC | 37.34 | 23927012 | |
| 365 | Ubiquitination | SPRHKQSPGHQDSDS CCCHHCCCCCCCCCC | 41.62 | 29967540 | |
| 370 | Phosphorylation | QSPGHQDSDSDLSPP CCCCCCCCCCCCCCC | 32.23 | 23927012 | |
| 372 | Phosphorylation | PGHQDSDSDLSPPRN CCCCCCCCCCCCCCC | 44.39 | 23927012 | |
| 375 | Phosphorylation | QDSDSDLSPPRNRPR CCCCCCCCCCCCCCC | 37.54 | 23927012 | |
| 382 | Ubiquitination | SPPRNRPRHRSSDSD CCCCCCCCCCCCCCC | 34.31 | 24816145 | |
| 385 | Phosphorylation | RNRPRHRSSDSDLSP CCCCCCCCCCCCCCC | 32.16 | 27273156 | |
| 386 | Phosphorylation | NRPRHRSSDSDLSPP CCCCCCCCCCCCCCC | 40.88 | 27273156 | |
| 388 | Phosphorylation | PRHRSSDSDLSPPRR CCCCCCCCCCCCCHH | 42.26 | 27273156 | |
| 391 | Phosphorylation | RSSDSDLSPPRRRQR CCCCCCCCCCHHHHC | 37.54 | 23401153 | |
| 399 | Phosphorylation | PPRRRQRTKSSDSDL CCHHHHCCCCCCCCC | 27.26 | 25072903 | |
| 401 | Phosphorylation | RRRQRTKSSDSDLSP HHHHCCCCCCCCCCC | 38.47 | 27273156 | |
| 402 | Phosphorylation | RRQRTKSSDSDLSPP HHHCCCCCCCCCCCC | 42.56 | 27273156 | |
| 404 | Phosphorylation | QRTKSSDSDLSPPRR HCCCCCCCCCCCCCC | 42.26 | 27273156 | |
| 407 | Phosphorylation | KSSDSDLSPPRRSQP CCCCCCCCCCCCCCC | 37.54 | 23401153 | |
| 423 | Phosphorylation | GKKAAHMYSGAKTGL CCCHHHHHHCCCHHH | 8.29 | 29396449 | |
| 424 | Phosphorylation | KKAAHMYSGAKTGLV CCHHHHHHCCCHHHH | 25.38 | 28985074 | |
| 427 | Acetylation | AHMYSGAKTGLVLTD HHHHHCCCHHHHHHH | 46.80 | 26051181 | |
| 428 | Phosphorylation | HMYSGAKTGLVLTDI HHHHCCCHHHHHHHH | 34.90 | 20068231 | |
| 433 | Phosphorylation | AKTGLVLTDIQREQQ CCHHHHHHHHHHHHH | 24.47 | 20068231 | |
| 458 | Phosphorylation | AFEAEFQYAETVFRD HHHHHHHHHHHHHCC | 16.24 | 27642862 | |
| 462 | Ubiquitination | EFQYAETVFRDKSGR HHHHHHHHHCCCCCC | 2.52 | 24816145 | |
| 483 | Ubiquitination | ERLEQRRKAEKDSER HHHHHHHHHHHHHHH | 64.19 | 24816145 | |
| 494 | Phosphorylation | DSERDELYAQWGKGL HHHHHHHHHHHHHHH | 8.49 | 28796482 | |
| 499 | Acetylation | ELYAQWGKGLAQSRQ HHHHHHHHHHHHHHH | 48.03 | 26051181 | |
| 499 | Ubiquitination | ELYAQWGKGLAQSRQ HHHHHHHHHHHHHHH | 48.03 | 29967540 | |
| 516 | Ubiquitination | QNVEDAMKEMQKPLA HCHHHHHHHHHHHHH | 52.32 | 24816145 | |
| 520 | Acetylation | DAMKEMQKPLARYID HHHHHHHHHHHHHCC | 40.46 | 25953088 | |
| 563 | Ubiquitination | ENKNKKVRPRYSGPA HCCCCCCCCCCCCCC | 20.89 | 24816145 | |
| 566 | Phosphorylation | NKKVRPRYSGPAPPP CCCCCCCCCCCCCCC | 22.21 | 19691289 | |
| 567 | Phosphorylation | KKVRPRYSGPAPPPN CCCCCCCCCCCCCCC | 39.31 | 26055452 | |
| 596 | Ubiquitination | RSNGFEQKRFARLAS CCCCHHHHHHHHHHC | 42.14 | 24816145 | |
| 612 | Phosphorylation | KAVEELAYKWSVEDM HHHHHHHHHCCCCCC | 26.14 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 18 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BUD13_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BUD13_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RBMX2_HUMAN | RBMX2 | physical | 22365833 | |
| GPKOW_HUMAN | GPKOW | physical | 22365833 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-159; SER-163; SER-271;THR-279; SER-325 AND SER-358, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-325, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-159; SER-163; SER-222;SER-226; SER-271; SER-325; SER-354 AND SER-358, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271; SER-281 ANDSER-325, AND MASS SPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-159; SER-163 ANDSER-325, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-135; SER-139; THR-147;SER-151; THR-159; SER-163; SER-222; SER-226; SER-248; SER-271 ANDSER-325, AND MASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-255, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-494, AND MASSSPECTROMETRY. | |